Geode Capital Management, LLC Minerva Neurosciences, Inc. Transaction History
Geode Capital Management, LLC
- $1.24 Trillion
- Q1 2025
A detailed history of Geode Capital Management, LLC transactions in Minerva Neurosciences, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 76,732 shares of NERV stock, worth $151,929. This represents 0.0% of its overall portfolio holdings.
Number of Shares
76,732
Previous 56,456
35.91%
Holding current value
$151,929
Previous $125,000
4.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NERV
# of Institutions
19Shares Held
1.95MCall Options Held
0Put Options Held
0-
Federated Hermes, Inc. Pittsburgh, PA1.35MShares$2.68 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA252KShares$499,0780.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny114KShares$225,9120.0% of portfolio
-
Black Rock Inc. New York, NY72.7KShares$143,8840.0% of portfolio
-
Apella Capital, LLC20.9KShares$41,4590.0% of portfolio
About Minerva Neurosciences, Inc.
- Ticker NERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,340,190
- Market Cap $10.6M
- Description
- Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein ...